Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Tianjin Selenium Aige Biotechnology Co., Ltd., established on 2010-12-08, Business scope includes biotechnology,Food Technology Development,transfer,consultation service,Layer farming,Wholesale and retail trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

J-Oil Mills, Inc. engages in the production, processing, and sale of fats and oil products. It operates through the following segments: Oils & Fats, Processed Products, Foodstuff & Fine Materials, and Others. The Oils & Fats segment supplies household and professional-use oils & fats, and oilseed meals. The Processed Products segment handles margarines, shortening, and powdered oils & fats. The Foodstuff & Fine Materials segment covers starch and chemical business promotions. The Others segment engages in the business of real estate leasing services. The company was founded on April 1, 2002 and is headquartered in Tokyo, Japan.

Chr. Hansen A/S is a global bioscience company based in Hørsholm, Denmark that develops natural solutions for the food, beverage, nutritional, pharmaceutical and agricultural industries. The company is a supplier of food cultures, probiotics, enzymes and natural colors. Its products are used in cheese production, fermented milk, meat, food service, beverages, wine, fruit preparation, ice cream and desserts, confectionery, cereals, spreads, bakery products, snacks, dietary supplements, pharmaceuticals and agricultural products. Chr. Hansen A/S has development centers in Denmark, the United States, France and Germany including research facilities in Denmark and France. A large percentage of the employees engage in research and development for the international food and pharmaceuticals industries.

Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient’s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

Unigen Co., Ltd. is a private company headquartered in the South Korea that manufactures health foods and cosmetics.

Beijing Liqianqiu Technology Development Co., Ltd., established on 2007-07-31, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Organize cultural and artistic exchange activities(Does not include commercial performances);Conference Services,Undertake exhibition and display activities;design,make,acting,Place an ad;Cultural Consulting;buisness planning,design;Economic and Trade Consulting.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

NattoPharma ASA engages in the manufacture and sale of nutritional and pharmaceutical products. It offers vitamin K2 under the product brand MenaQ7. The company was founded by Frode Marc Bohan on November 4, 2004 and is headquartered in Oslo, Norway.

Baxter AG, part of Baxter International, Inc., is a company headquartered in Volketswell, Switzerland. The firm wholesales pharmaceutical products.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

VitaK BV develops nutritional supplements and healthy foods. Its services include human trial center, research and development, MGP center, vitamin K, expert center, and consultancy. The company was founded by Cees Vermeer in 2001 and is headquartered in Maastricht, the Netherlands.

Estabished in1950, Snow Brand Milk Products Co. Ltd. is a Japanese dairy company that manufactures cheese, butter, milk and other dairy products. They also manufacture fruit juices and frozen desserts and offers home milk delivery service. Snow Brand has several offices and factories around Japan.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Baxalta GmbH, a subsidiary of Takeda Pharmaceutical Co., Ltd., is a Swiss company located in Glattpark that manufactures and wholesales pharmaceutical products. It was founded in 2000. Julie So-Young Kim is currently the CEO of the firm.

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.

Changsha Ruidokang Biotechnology Co., Ltd., established on 2016-09-29, Business scope includes biological products,R&D of cosmetics;Biotechnology Extension Services;Food Science and Technology Research Services;Agricultural projects and technology consulting services;Agricultural technology extension service;food sales(limited branch);Biological Products Sales(limited branch);Cosmetic production(limited branch);Retailing of cosmetics and hygiene products;Sales of laboratory equipment and ventilation systems;Biological product production(limited branch).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)